Advantagene, Inc. (Advantagene)

Oncology Corporate Profile

HQ Location

440 Lexington Avenue
Auburndale, MA 2466

Company Description

Advantagene is a Boston-area privately held biopharmaceutical company focused on preventing the recurrence and progression of cancer through the use of novel therapeutics in oncology and immunotherapy that improve current care. Founded in 1999, the company's experience and expertise has continuously progressed, providing a strong foundation for its work developing, manufacturing and testing gene-based biologics at the forefront of biomedical research. Advantagene strives to address areas of unmet medical need while maintaining lower long-term costs for patients. The company is developing and testing possible cancer treatment products with breakaway potential.

Website: http://www.advantagene.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
GMCIimmunotherapyProstate cancerIII
GMCIimmunotherapyGliomaII
GMCIimmunotherapyNon Small Cell Lung Cancer (NSCLC)I
GMCIimmunotherapyPancreatic cancerINUL

View additional information on product candidates here »

Source: http://www.advantagene.com

Recent News Headlines

There are no news items to display